Passpass: Viernheim and Ried fight for missing medication

Passpass: Viernheim and Ried fight for missing medication

In the past few days, a worrying pattern has occurred in the pharmacies of Viernheim and the surrounding Ried municipalities: patients and customers often face empty shelves when looking for certain medication. This currently not only affects everyday saline solution, but also important antibiotics that are essential for many people. It is no secret that the shortage of medication has already triggered a number of discussions in Germany and that more and more people are wondering why this is happening.

The lack of certain drugs is not new, but the frequency and variety of the missing medication seem to be increasing. While they were just a few specific products, there are now reports that even basic medications are not available for a long time. The reasons for this are varied and range from delivery bottlenecks to production problems to an increased demand that cannot be covered.

causes of the shortage of drugs

pharmaceutical companies often face challenges in the production and delivery of their products. This can lead to unexpected disorders that have an effect in the entire supply chain. Whether natural disasters, sudden production stops or increased raw materials - each of these factors can lead to important medication not available at short notice.

Another factor that contributes to scarcity is the growing number of patients who rely on certain drug treatments. In particular, antibiotics used to treat bacterial infections should always be available. But increasingly, patients have to fall back on alternatives for various reasons.

The situation was further tightened by the Covid 19 pandemic. Many production lines, which were originally geared towards providing research and vaccines, have been reversed or suffered delays, which suffers the availability of other medications. This development has once again raised awareness of the fragility of pharmaceutical logistics.

Some pharmacists report on site that they are able to support their customers at least temporarily by pre -orders or switching to other preparations, but this is not a solution in any case. The increasing uncertainty ensures that patients relatives, especially in the elderly or chronically ill who rely on regular medication.

Nevertheless, it remains to be seen whether and when the pharmaceutical companies are able to increase their production capacities and ensure the availability of the most sought -after medication in the long term. The coming time will be crucial to see whether the situation improves or whether there will be further bottlenecks.

For more detailed information on the individual drugs and current developments, those affected and interested should regularly the website www.mannheimer-morgen.de Consult because there is continuously reported on the situation in the region.